Status:
COMPLETED
Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children
Lead Sponsor:
All India Institute of Medical Sciences
Conditions:
Status Epilepticus
Seizures
Eligibility:
All Genders
6-14 years
Phase:
PHASE3
Brief Summary
Status epilepticus (SE) is a common pediatric emergency which is potentially life-threatening and requires rapid termination. Early and effective treatment is essential to prevent the morbidity and mo...
Eligibility Criteria
Inclusion
- Children presenting convulsing to the pediatric emergency or developing seizure while in casualty
- Age 6-14 years
Exclusion
- Known hypersensitivity to any benzodiazepine
- Child has received any parenteral anti-convulsant within 1 hr prior to enrollment
- Presence of severe cardio-respiratory compromise or cardiac arrhythmias
- Presence of upper respiratory tract infection
- Presence of basal skull fracture causing cerebro-spinal fluid (CSF) rhinorrhea
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2009
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00735527
Start Date
May 1 2008
End Date
April 1 2009
Last Update
May 5 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, India, 110029